These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 15454404)

  • 1. More than a monolayer: relating lung surfactant structure and mechanics to composition.
    Alonso C; Alig T; Yoon J; Bringezu F; Warriner H; Zasadzinski JA
    Biophys J; 2004 Dec; 87(6):4188-202. PubMed ID: 15454404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keeping lung surfactant where it belongs: protein regulation of two-dimensional viscosity.
    Alonso C; Waring A; Zasadzinski JA
    Biophys J; 2005 Jul; 89(1):266-73. PubMed ID: 15833995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modifying calf lung surfactant by hexadecanol.
    Alonso C; Bringezu F; Brezesinski G; Waring AJ; Zasadzinski JA
    Langmuir; 2005 Feb; 21(3):1028-35. PubMed ID: 15667185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Langmuir monolayer of artificial pulmonary surfactant mixtures with an amphiphilic peptide at the air/water interface: comparison of new preparations with surfacten (Surfactant TA).
    Nakahara H; Lee S; Sugihara G; Chang CH; Shibata O
    Langmuir; 2008 Apr; 24(7):3370-9. PubMed ID: 18315015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase transitions in films of lung surfactant at the air-water interface.
    Nag K; Perez-Gil J; Ruano ML; Worthman LA; Stewart J; Casals C; Keough KM
    Biophys J; 1998 Jun; 74(6):2983-95. PubMed ID: 9635752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lung surfactant proteins, SP-B and SP-C, and palmitic acid on monolayer stability.
    Ding J; Takamoto DY; von Nahmen A; Lipp MM; Lee KY; Waring AJ; Zasadzinski JA
    Biophys J; 2001 May; 80(5):2262-72. PubMed ID: 11325728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary surfactant protein C containing lipid films at the air-water interface as a model for the surface of lung alveoli.
    Post A; Nahmen AV; Schmitt M; Ruths J; Riegler H; Sieber M; Galla HJ
    Mol Membr Biol; 1995; 12(1):93-9. PubMed ID: 7767391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adsorption of pulmonary surfactant protein SP-A to monolayers of phospholipids containing hydrophobic surfactant protein SP-B or SP-C: potential differential role for tertiary interaction of lipids, hydrophobic proteins, and SP-A.
    Taneva SG; Keough KM
    Biochemistry; 2000 May; 39(20):6083-93. PubMed ID: 10821681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of hydrophobic alkylated gold nanoparticles on the phase behavior of monolayers of DPPC and clinical lung surfactant.
    Tatur S; Badia A
    Langmuir; 2012 Jan; 28(1):628-39. PubMed ID: 22118426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The melting of pulmonary surfactant monolayers.
    Yan W; Biswas SC; Laderas TG; Hall SB
    J Appl Physiol (1985); 2007 May; 102(5):1739-45. PubMed ID: 17194731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interfacial curvature effects on the monolayer morphology and dynamics of a clinical lung surfactant.
    Sachan AK; Zasadzinski JA
    Proc Natl Acad Sci U S A; 2018 Jan; 115(2):E134-E143. PubMed ID: 29279405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural characterization of the monolayer-multilayer transition in a pulmonary surfactant model: IR studies of films transferred at continuously varying surface pressures.
    Mao G; Desai J; Flach CR; Mendelsohn R
    Langmuir; 2008 Mar; 24(5):2025-34. PubMed ID: 18198907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tensiometric and Phase Domain Behavior of Lung Surfactant on Mucus-like Viscoelastic Hydrogels.
    Schenck DM; Fiegel J
    ACS Appl Mater Interfaces; 2016 Mar; 8(9):5917-28. PubMed ID: 26894883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid-crystalline collapse of pulmonary surfactant monolayers.
    Schief WR; Antia M; Discher BM; Hall SB; Vogel V
    Biophys J; 2003 Jun; 84(6):3792-806. PubMed ID: 12770885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluidization of a dipalmitoyl phosphatidylcholine monolayer by fluorocarbon gases: potential use in lung surfactant therapy.
    Gerber F; Krafft MP; Vandamme TF; Goldmann M; Fontaine P
    Biophys J; 2006 May; 90(9):3184-92. PubMed ID: 16500985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of lung surfactant proteins with anionic phospholipids.
    Takamoto DY; Lipp MM; von Nahmen A; Lee KY; Waring AJ; Zasadzinski JA
    Biophys J; 2001 Jul; 81(1):153-69. PubMed ID: 11423403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of eicosane, a component of nanoparticles in diesel exhaust, on surface activity of pulmonary surfactant monolayers.
    Kanno S; Furuyama A; Hirano S
    Arch Toxicol; 2008 Nov; 82(11):841-50. PubMed ID: 18488198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-resolution studies of lung surfactant collapse.
    Sibug-Aga R; Dunn RC
    Photochem Photobiol; 2004; 80(3):471-6. PubMed ID: 15623332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of surfactant protein A on regional organization of phospholipid monolayers containing surfactant protein B or C.
    Taneva SG; Keough KM
    Biophys J; 2000 Oct; 79(4):2010-23. PubMed ID: 11023905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of phase transition in adsorbed monolayers at the air/water interface.
    Vollhardt D; Fainerman VB
    Adv Colloid Interface Sci; 2010 Feb; 154(1-2):1-19. PubMed ID: 20153454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.